Bibliography for Item 2 in BGP: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
No edit summary
No edit summary
 
(6 intermediate revisions by the same user not shown)
Line 1: Line 1:
==Primary Links==
==Used Resources==


*Alonso-Zaldivar, Ricardo, “FDA pledges openness on gene-altered products,” wtop.com, January 15, 2009. Last Accessed March 14, 2009. http://www.wtopnews.com/?nid=106&sid=1575167
* Beyond Borders: Global Biotechnology report, 2007. Ernst and Young. Available at: http://www.ey.com/global/content.nsf/International/Biotechnology_Library_Beyond_Borders_2007
*Bio, ''Biotechnology Industry Facts'', http://www.bio.org/speeches/pubs/er/statistics.asp
**sales, revenue, number of companies, and R&D investment by year
*Bio, ''Industry At-a-Glance'', 2009, http://bio.org/ataglance/
** defines industry, applications, processes and timeline
*Biotech Institute, ''Industry Facts'', 2005, http://www.biotechinstitute.org/what_is/industry_facts.html
** defines key sub-industries of biotech, as well as 'fun facts' about the industry: who regulates it, how much is spent on R&D, etc. No systematic presentation of information
*CNNMoney, ''Biotechnology'', 2009, http://money.cnn.com/data/sectors/Biotechnology/
** stock ticker for biotech companies


*http://www.hoovers.com/biotechnology-sector/--ID__174--/free-ind-fr-profile-basic.xhtml
* Council for Entrepreneurial Development, "2007 CED North Carolina Venture Report." 2007.
 
* Gaisford, James D., and Jill E. Hobbs, William A. Kerr, Nicholas Perdikis, Mari D. Plunkett, ''The Economics of Biotechnology. ''Cheltenham, UK. Edward Elgar, 2001.
 
*Guo, Re-Jing, Baruch Lev, and Nan Zhou, “Competitive Costs of Disclosure by Biotech IPOs” Journal of Accounting Research, Vo. 42 No. 2 May 2004
 
*Hoovers: A D&B Company, ''Industry Overview: Biotechnology Sector'' http://www.hoovers.com/biotechnology-sector/--ID__174--/free-ind-fr-profile-basic.xhtml
** describes basic methods, costs, and goals of the biotech industry
** describes basic methods, costs, and goals of the biotech industry


*http://www.ibisworld.com/industry/retail.aspx?indid=2001&chid=1
*IBISWorld, ''Biotechnology'', Mar 11 2009, http://www.ibisworld.com/industry/retail.aspx?indid=2001&chid=1
** identifies key products and services, as well as market size and distribution
** identifies key products and services, as well as market size and distribution


*http://www.biotechinstitute.org/what_is/industry_facts.html
* Kalil, Thomas, ''University-Industry Partnerships in the Life Sciences: A University of California, Berkeley Perspective'', in Biotechnology: Essays from its Heartland, Lynn Yarris, ed. San Francisco: BASIC, 2004.
** defines key sub-industries of biotech, as well as 'fun facts' about the industry: who regulates it, how much is spent on R&D, etc. No systematic presentation of information
 
*Maggon, Krishnan, ''Pharmaceutical and Biotechnology Industry Overview 2007'', Knol, http://knol.google.com/k/krishan-maggon/pharmaceutical-and-biotechnology/3fy5eowy8suq3/4#
** hard to measure biotech productivity. No clear connection between R&D investment and payoff


*http://www.bio.org/speeches/pubs/er/statistics.asp
* McKelvey, Maureen, Annika Rickne and Jens Laage-Hellman, “Stylized facts about innovation processes in modern biotechnology,” in The Economic Dynamics of Modern Biotechnology. Cheltenham, UK: Edward Elgar, 2004.  
**sales, revenue, number of companies, and R&D investment by year
** Information about innovation processes


*http://bio.org/ataglance/
* Oliver, Amalya L., "University-Based Biotechnology Spin-Offs," in ''Handbook of Bioentrepreneurship'', Holger Patzelt and Thomas Brenner, eds. New York: Springer, 2008
** defines industry, applications, processes and timeline


*http://knol.google.com/k/krishan-maggon/pharmaceutical-and-biotechnology/3fy5eowy8suq3/4#
* Oliver, Richard, ''The Coming Biotech Age: The Business of Bio-Materials'', New York: McGraw-Hill, 2000.
** hard to measure biotech productivity. No clear connection between R&D investment and payoff


*http://rsss.anu.edu.au/~janeth/BiotechInd.html
*Open Source Biotechnology Project, ''Biotechnology industry overview'', 2002 http://rsss.anu.edu.au/~janeth/BiotechInd.html
** major research tools and products
** major research tools and products


*http://rsss.anu.edu.au/~janeth/IPIndust.html
*Open Source Biotechnology Project, ''Intellectual Property and Industry Structure'', http://rsss.anu.edu.au/~janeth/IPIndust.html, 1999
** problems of intellectual property regimes in Biotech, with specific reference to anticommons problems in the Agriculture Biotech industry
** problems of intellectual property regimes in Biotech, with specific reference to anticommons problems in the Agriculture Biotech industry


*http://biz.yahoo.com/ic/515.html
* Pareras, Luis, "Biotech Business Models," ''Healthonomics'', January 6, 2008/. Last Accessed March 13, 2009. Available at: http://www.healthonomics.org/2008/01/biotech-business-models.html
 
* Penhoet, Ed. "The Biotechnology Industry from Birth to Adolescence", in ''Biotechnology: Essays from its Heartland, ''Lynn Yarris, ed. San Francisco: BASIC, 2004.
 
* Pisano, Gary P., "Can Science Be a Business? Lessons from Biotech" Harvard Business Review, Oct2006, Vol. 84 Issue 10, p114-125
 
* Pisano, Gary P. ''Science Business: The Promise, the Reality, and the Future of Biotech,'' Boston: Harvard Business School Press, 2006.
 
* Phillips, Theresa, "Biotech Business Models," ''About.com,'' September 19, 2007. Last Accessed March 13, 2009. Available at: [http://biotech.about.com/b/2007/09/19/biotech-business-models.htm http://biotech.about.com/b/2007/09/19/biotech-business-models.htm]
 
*Yahoo Inc., ''Industry Center - Biotechnology'', 2009 http://biz.yahoo.com/ic/515.html
** stock ticker for biotech companies
** stock ticker for biotech companies


*http://money.cnn.com/data/sectors/Biotechnology/
* Jaffe,A . M. Trajtenberg, R. Henderson. 1993. Geographiclo calization of knowledge spillovers as evidenced by patent citations. Quart. J. Econom. 63 577-598.  
** stock ticker for biotech companies


* Penhoet, Ed. "The Biotechnology Industry from Birth to Adolescence", in ''Biotechnology: Essays from its Heartland, ''Lynn Yarris, ed. San Francisco: BASIC, 2004.
* Robert Kaiser and Michael Liecke, “Regional Knowledge Dynamics in the Biotechnology Industry: A Conceptual Framework for Micro-Level Analysis” University of Munich


* Phillips, Theresa, "Biotech Business Models," ''About.com,'' September 19, 2007. Last Accessed March 13, 2009. Available at: [http://biotech.about.com/b/2007/09/19/biotech-business-models.htm http://biotech.about.com/b/2007/09/19/biotech-business-models.htm]
* Helena Yli-Renko, Erkko Autio, Harry J. Sapienza , “Social Capital, Knowledge Acquisition, and Knowledge Exploitation in Young Technology-Based Firms,” Strategic Management Journal, Vol. 22, No. 6/7, Special Issue: Strategic Entrepreneurship: Entrepreneurial Strategies for Wealth Creation (Jun. - Jul., 2001), pp. 587-613


* Pareras, Luis, "Biotech Business Models," ''Healthonomics'', January 6, 2008/. Last Accessed March 13, 2009. Available at: http://www.healthonomics.org/2008/01/biotech-business-models.html
* Joel A. C. Baum, Tony Calabrese, Brian S. Silverman , “Don't Go It Alone: Alliance Network Composition and Startups' Performance in Canadian Biotechnology,” Strategic Management Journal, Vol. 21, No. 3, Special Issue: Strategic Networks (Mar., 2000), pp. 267-294


* McKelvey, Maureen, Annika Rickne and Jens Laage-Hellman, “Stylized facts about innovation processes in modern biotechnology,” in The Economic Dynamics of Modern Biotechnology. Cheltenham, UK: Edward Elgar, 2004.  
*NCBI, "Our Mission," May 21 2004, http://www.ncbi.nlm.nih.gov/About/glance/ourmission.html
** Information about innovation processes


* Kalil, Thomas, University-Industry Partnerships in the Life Sciences: A University of California, Berkeley Perspective,
*NCBI, "Programs and Activities," May 21 2004, http://www.ncbi.nlm.nih.gov/About/glance/programs.html


* Oliver, Richard, ''The Coming Biotech Age: The Business of Bio-Materials'', New York: McGraw-Hill, 2000.
*NCBI, "Human Genome Resources," http://www.ncbi.nlm.nih.gov/genome/guide/human/


* Gaisford, James D., and Jill E. Hobbs, William A. Kerr, Nicholas Perdikis, Mari D. Plunkett, ''The Economics of Biotechnology. ''Cheltenham, UK. Edward Elgar, 2001.
*Bownas, Jennifer, "Accessing records in NCBI's sequence databases" U.S. Department of Energy Biological and Environmental Research program, January 2 2003, http://www.ornl.gov/sci/techresources/Human_Genome/posters/chromosome/sequence.shtml


* Beyond Borders: Global Biotechnology report, 2007. Ernst and Young. Available at: http://www.ey.com/global/content.nsf/International/Biotechnology_Library_Beyond_Borders_2007
*NCBI, "Sequence Identifiers: A Historical Note," June 14 2004, http://www.ncbi.nlm.nih.gov/Sitemap/sequenceIDs.html


* Council for Entrepreneurial Development, "2007 CED North Carolina Venture Report." 2007.
*NIH, "National Institutes of Health Public Access," http://publicaccess.nih.gov/


* Pisano, Gary P., "Can Science Be a Business? Lessons from Biotech" Harvard Business Review, Oct2006, Vol. 84 Issue 10, p114-125
*Science Commons, "NIH Mandate Made Permanent" March 17 2009 http://sciencecommons.org/weblog/archives/2009/03/17/nih-mandate-made-permanent/


*Guo, Re-Jing, Baruch Lev, and Nan Zhou, “Competitive Costs of Disclosure by Biotech IPOs” Journal of Accounting Research, Vo. 42 No. 2 May 2004
*NCBI, "The NCBI Handbook" http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=handbook


*Alonso-Zaldivar, Ricardo, “FDA pledges openness on gene-altered products,” wtop.com, January 15, 2009. Last Accessed March 14, 2009. http://www.wtopnews.com/?nid=106&sid=1575167
*NIH Working Group on Research Tools, "Report of the National Institutes of Health (NIH) Working Group on Research Tools" June 4 1998, http://www.nih.gov/news/researchtools/


* Pisano, Gary P. ''Science Business: The Promise, the Reality, and the Future of Biotech,'' Boston: Harvard Business School Press, 2006.
*Trans-NIH Mouse Initiatives, "Frequently Asked Questions (FAQs) and Answers" http://www.nih.gov/science/models/mouse/sharing/5.html


* Oliver, Amalya L., "University-Based Biotechnology Spin-Offs," in ''Handbook of Bioentrepreneurship'', Holger Patzelt and Thomas Brenner, eds. New York: Springer, 2008
*Ladas & Parry "Patentability of Process Claims in the United States," August 14 1996 http://www.ladas.com/Patents/Biotechnology/Durden-ProcessClaims.html


==Secondary links==
==Unused Resources==


* New York Biotechnology Association, <http://www.nyba.org/>
* New York Biotechnology Association, <http://www.nyba.org/>
Line 112: Line 141:
*''Common ground on the critical path'' Nature Reviews Drug Discovery Vol. 5, No. 267,April 2006, <http://www.nature.com/nrd/journal/v5/n4/abs/nrd2019.html>
*''Common ground on the critical path'' Nature Reviews Drug Discovery Vol. 5, No. 267,April 2006, <http://www.nature.com/nrd/journal/v5/n4/abs/nrd2019.html>


==Books: (some you can read online)==


*Friedman, Yali. ''Building Biotechnology'', Thinkbiotech: 2006. <http://www.amazon.com/Building-Biotechnology-Business-Regulations-Politics/dp/0973467665/ref=si3_rdr_bb_product>
*Friedman, Yali. ''Building Biotechnology'', Thinkbiotech: 2006. <http://www.amazon.com/Building-Biotechnology-Business-Regulations-Politics/dp/0973467665/ref=si3_rdr_bb_product>
Line 128: Line 156:
*Acharya, Rohini, ''The Emergence and Growth of Biotechnology: Experiences in Industrialized and Developing Countries''. Cheltanham, UK: Edward Elgar, 1999.
*Acharya, Rohini, ''The Emergence and Growth of Biotechnology: Experiences in Industrialized and Developing Countries''. Cheltanham, UK: Edward Elgar, 1999.


==Others==
*Office of Biotechnology Activities, ''Welcome to OBA'', http://oba.od.nih.gov/oba/index.html
*Office of Biotechnology Activities, ''Welcome to OBA'', http://oba.od.nih.gov/oba/index.html


==Blogs==
*''Patent Baristas'', http://patentbaristas.com/
*''Patent Baristas'', http://patentbaristas.com/
==Navigation==
[[Give an overall picture of the BGP field]]<br>
[[Biotechnology_-_Genomic_and_Proteomics]]

Latest revision as of 11:23, 3 May 2009

Used Resources

  • Council for Entrepreneurial Development, "2007 CED North Carolina Venture Report." 2007.
  • Gaisford, James D., and Jill E. Hobbs, William A. Kerr, Nicholas Perdikis, Mari D. Plunkett, The Economics of Biotechnology. Cheltenham, UK. Edward Elgar, 2001.
  • Guo, Re-Jing, Baruch Lev, and Nan Zhou, “Competitive Costs of Disclosure by Biotech IPOs” Journal of Accounting Research, Vo. 42 No. 2 May 2004
  • Kalil, Thomas, University-Industry Partnerships in the Life Sciences: A University of California, Berkeley Perspective, in Biotechnology: Essays from its Heartland, Lynn Yarris, ed. San Francisco: BASIC, 2004.
  • McKelvey, Maureen, Annika Rickne and Jens Laage-Hellman, “Stylized facts about innovation processes in modern biotechnology,” in The Economic Dynamics of Modern Biotechnology. Cheltenham, UK: Edward Elgar, 2004.
    • Information about innovation processes
  • Oliver, Amalya L., "University-Based Biotechnology Spin-Offs," in Handbook of Bioentrepreneurship, Holger Patzelt and Thomas Brenner, eds. New York: Springer, 2008
  • Oliver, Richard, The Coming Biotech Age: The Business of Bio-Materials, New York: McGraw-Hill, 2000.
  • Open Source Biotechnology Project, Intellectual Property and Industry Structure, http://rsss.anu.edu.au/~janeth/IPIndust.html, 1999
    • problems of intellectual property regimes in Biotech, with specific reference to anticommons problems in the Agriculture Biotech industry
  • Penhoet, Ed. "The Biotechnology Industry from Birth to Adolescence", in Biotechnology: Essays from its Heartland, Lynn Yarris, ed. San Francisco: BASIC, 2004.
  • Pisano, Gary P., "Can Science Be a Business? Lessons from Biotech" Harvard Business Review, Oct2006, Vol. 84 Issue 10, p114-125
  • Pisano, Gary P. Science Business: The Promise, the Reality, and the Future of Biotech, Boston: Harvard Business School Press, 2006.
  • Jaffe,A . M. Trajtenberg, R. Henderson. 1993. Geographiclo calization of knowledge spillovers as evidenced by patent citations. Quart. J. Econom. 63 577-598.
  • Robert Kaiser and Michael Liecke, “Regional Knowledge Dynamics in the Biotechnology Industry: A Conceptual Framework for Micro-Level Analysis” University of Munich
  • Helena Yli-Renko, Erkko Autio, Harry J. Sapienza , “Social Capital, Knowledge Acquisition, and Knowledge Exploitation in Young Technology-Based Firms,” Strategic Management Journal, Vol. 22, No. 6/7, Special Issue: Strategic Entrepreneurship: Entrepreneurial Strategies for Wealth Creation (Jun. - Jul., 2001), pp. 587-613
  • Joel A. C. Baum, Tony Calabrese, Brian S. Silverman , “Don't Go It Alone: Alliance Network Composition and Startups' Performance in Canadian Biotechnology,” Strategic Management Journal, Vol. 21, No. 3, Special Issue: Strategic Networks (Mar., 2000), pp. 267-294

Unused Resources


  • Acharya, Rohini, The Emergence and Growth of Biotechnology: Experiences in Industrialized and Developing Countries. Cheltanham, UK: Edward Elgar, 1999.

Navigation

Give an overall picture of the BGP field
Biotechnology_-_Genomic_and_Proteomics